CareDx, Inc (CDNA)

NASDAQ: CDNA · IEX Real-Time Price · USD
12.01
+1.37 (12.88%)
At close: Mar 1, 2024, 4:00 PM
11.81
-0.20 (-1.67%)
After-hours: Mar 1, 2024, 7:59 PM EST

CareDx Revenue

CareDx had revenue of $280.32M in the twelve months ending December 31, 2023, down -12.89% year-over-year. Revenue in the quarter ending December 31, 2023 was $65.57M, a -20.41% decrease year-over-year. In the year 2023, CareDx had annual revenue of $280.32M, a decrease of -12.89%.

Revenue (ttm)
$280.32M
Revenue Growth
-12.89%
P/S Ratio
2.43
Revenue / Employee
$385,590
Employees
727
Market Cap
681.10M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023280.32M-41.47M-12.89%
Dec 31, 2022321.79M25.40M8.57%
Dec 31, 2021296.40M104.20M54.22%
Dec 31, 2020192.19M65.13M51.25%
Dec 31, 2019127.07M50.50M65.95%
Dec 31, 201876.57M28.25M58.45%
Dec 31, 201748.32M7.69M18.93%
Dec 31, 201640.63M12.49M44.37%
Dec 31, 201528.14M838.00K3.07%
Dec 31, 201427.31M5.21M23.57%
Dec 31, 201322.10M1.65M8.05%
Dec 31, 201220.45M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orthofix Medical 668.46M
The Pennant Group 523.60M
OraSure Technologies 452.67M
Revance Therapeutics 214.16M
Avid Bioservices 140.94M
Mersana Therapeutics 40.84M
Nyxoah 4.08M
Revenue Rankings